058b0cd044411307dc4e4ad9c2339614  238817.pdf
0959e0b01a89cda1270fcab0b433b3961d380634  238817.pdf
24f6597444d3b9844a95acab9591e36b52971ed833a97004228cfc63fbb28a08  238817.pdf

Title:          3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
Subject:        Lancet Oncology, 19 (2018) 562-578. doi:10.1016/S1470-2045(18)30093-7
Keywords:       
Author:         Timothy J Iveson MD
Creator:        Elsevier
Producer:       Acrobat Distiller 6.0 for Windows
CreationDate:   Sat Mar 17 13:22:20 2018 CET
ModDate:        Fri Apr 13 07:34:56 2018 CEST
Tagged:         no
UserProperties: no
Suspects:       no
Form:           none
JavaScript:     no
Pages:          17
Encrypted:      no
Page size:      595.276 x 799.37 pts
Page rot:       0
File size:      2015302 bytes
Optimized:      yes
PDF version:    1.7


name                                 type              encoding         emb sub uni object ID
------------------------------------ ----------------- ---------------- --- --- --- ---------
NQNDRG+Shaker2Lancet-Bold            Type 1C           Custom           yes yes yes    105  0
GHVNXU+Shaker2Lancet-Regular         Type 1C           Custom           yes yes yes    106  0
FZLHJW+Shaker2Lancet-Italic          Type 1C           WinAnsi          yes yes yes    107  0
FZLHJW+ScalaLancetPro-Bold           Type 1C           Custom           yes yes yes    108  0
FZLHJW+ScalaLancetPro                Type 1C           Custom           yes yes yes    123  0
FZLHJW+Shaker2Lancet-BoldItalic      Type 1C           Custom           yes yes yes    124  0
NQNDRG+Shaker2Lancet-Bold            Type 1C           WinAnsi          yes yes yes    145  0
NQNDRG+Shaker2Lancet-Bold            Type 1C           WinAnsi          yes yes yes     55  0
FZLHJW+ScalaLancetPro-Italic         Type 1C           WinAnsi          yes yes yes     57  0
NQNDRG+Shaker2Lancet-Bold            Type 1C           WinAnsi          yes yes yes     59  0
GHVNXU+Shaker2Lancet-Regular         Type 1C           Custom           yes yes no      65  0
NQNDRG+Shaker2Lancet-Bold            Type 1C           WinAnsi          yes yes no      64  0
NQNDRG+Shaker2Lancet-Bold            Type 1C           WinAnsi          yes yes no      68  0
GHVNXU+Shaker2Lancet-Regular         Type 1C           Custom           yes yes no      67  0
FZLHJW+Shaker2Lancet-BoldItalic      Type 1C           WinAnsi          yes yes no      72  0
GHVNXU+Shaker2Lancet-Regular         Type 1C           Custom           yes yes no      75  0
NQNDRG+Shaker2Lancet-Bold            Type 1C           WinAnsi          yes yes no      74  0
GHVNXU+Shaker2Lancet-Regular         Type 1C           Custom           yes yes no      76  0
NQNDRG+Shaker2Lancet-Bold            Type 1C           WinAnsi          yes yes no      73  0
NQNDRG+Shaker2Lancet-Bold            Type 1C           WinAnsi          yes yes no      78  0
GHVNXU+Shaker2Lancet-Regular         Type 1C           Custom           yes yes no      77  0
GHVNXU+Shaker2Lancet-Regular         Type 1C           WinAnsi          yes yes no      81  0
GHVNXU+Shaker2Lancet-Regular         Type 1C           WinAnsi          yes yes no      83  0
NQNDRG+Shaker2Lancet-Bold            Type 1C           WinAnsi          yes yes no      82  0
GHVNXU+Shaker2Lancet-Regular         Type 1C           Custom           yes yes no      79  0
NQNDRG+Shaker2Lancet-Bold            Type 1C           WinAnsi          yes yes no      80  0
NQNDRG+Shaker2Lancet-Bold            Type 1C           WinAnsi          yes yes no      86  0
GHVNXU+Shaker2Lancet-Regular         Type 1C           Custom           yes yes no      85  0
NQNDRG+Shaker2Lancet-Bold            Type 1C           WinAnsi          yes yes no      84  0
GHVNXU+Shaker2Lancet-Regular         Type 1C           WinAnsi          yes yes no      88  0
GHVNXU+Shaker2Lancet-Regular         Type 1C           WinAnsi          yes yes no      87  0


Jhove (Rel. 1.22.1, 2019-04-17)
 Date: 2021-04-22 02:47:55 CEST
 RepresentationInformation: 238817.pdf
  ReportingModule: PDF-hul, Rel. 1.12.1 (2019-04-17)
  LastModified: 2021-04-21 18:38:33 CEST
  Size: 2015302
  Format: PDF
  Version: 1.7
  Status: Well-Formed and valid
  SignatureMatches:
   PDF-hul
  MIMEtype: application/pdf
  Profile: Linearized PDF
  PDFMetadata: 
   Objects: 177
   FreeObjects: 1
   IncrementalUpdates: 1
   DocumentCatalog: 
    ViewerPreferences: 
     HideToolbar: false
     HideMenubar: false
     HideWindowUI: false
     FitWindow: false
     CenterWindow: false
     DisplayDocTitle: false
     NonFullScreenPageMode: UseNone
     Direction: L2R
     ViewArea: CropBox
     ViewClip: CropBox
     PrintArea: CropBox
     PageClip: CropBox
    PageLayout: SinglePage
    PageMode: UseOutlines
    Language: en-GB
    Outlines: 
     Item: 
      Title: 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
      Children: 
       Item: 
        Title: Introduction
       Item: 
        Title: Methods
        Children: 
         Item: 
          Title: Study design and participants
         Item: 
          Title: Randomisation and masking
         Item: 
          Title: Procedures
         Item: 
          Title: Outcomes
         Item: 
          Title: Statistical analysis
         Item: 
          Title: Role of the funding source
       Item: 
        Title: Results
       Item: 
        Title: Discussion
       Item: 
        Title: Acknowledgments
       Item: 
        Title: References
   Info: 
    Title: 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
    Author: Timothy J Iveson MD
    Subject: Lancet Oncology, 19 (2018) 562-578. doi:10.1016/S1470-2045(18)30093-7
    Keywords: 
    Creator: Elsevier
    Producer: Acrobat Distiller 6.0 for Windows
    CreationDate: Sat Mar 17 13:52:20 CET 2018
    ModDate: Fri Apr 13 08:04:56 CEST 2018
   ID: 0x0204ea99ea0842ff8c231ae8eaf73457, 0xbe1b1f1d24a7c7478f7fd980a368ad9e
   Filters: 
    FilterPipeline: FlateDecode
   Fonts: 
    Type1: 
     Font: 
      BaseFont: NQNDRG+Shaker2Lancet-Bold
      FontSubset: true
      FirstChar: 32
      LastChar: 32
      FontDescriptor: 
       FontName: NQNDRG+Shaker2Lancet-Bold
       Flags: Nonsymbolic
       FontBBox: -164, -241, 1109, 981
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GHVNXU+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 31
      LastChar: 134
      FontDescriptor: 
       FontName: GHVNXU+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
     Font: 
      BaseFont: GHVNXU+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 31
      LastChar: 183
      FontDescriptor: 
       FontName: GHVNXU+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
     Font: 
      BaseFont: NQNDRG+Shaker2Lancet-Bold
      FontSubset: true
      FirstChar: 32
      LastChar: 121
      FontDescriptor: 
       FontName: NQNDRG+Shaker2Lancet-Bold
       Flags: Nonsymbolic
       FontBBox: -164, -241, 1109, 981
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: FZLHJW+Shaker2Lancet-BoldItalic
      FontSubset: true
      FirstChar: 115
      LastChar: 118
      FontDescriptor: 
       FontName: FZLHJW+Shaker2Lancet-BoldItalic
       Flags: Nonsymbolic, Italic
       FontBBox: -185, -241, 1072, 981
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: NQNDRG+Shaker2Lancet-Bold
      FontSubset: true
      FirstChar: 32
      LastChar: 183
      FontDescriptor: 
       FontName: NQNDRG+Shaker2Lancet-Bold
       Flags: Nonsymbolic
       FontBBox: -164, -241, 1109, 981
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: NQNDRG+Shaker2Lancet-Bold
      FontSubset: true
      FirstChar: 47
      LastChar: 118
      FontDescriptor: 
       FontName: NQNDRG+Shaker2Lancet-Bold
       Flags: Nonsymbolic
       FontBBox: -164, -241, 1109, 981
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GHVNXU+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 1
      LastChar: 173
      FontDescriptor: 
       FontName: GHVNXU+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
     Font: 
      BaseFont: GHVNXU+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 1
      LastChar: 173
      FontDescriptor: 
       FontName: GHVNXU+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
     Font: 
      BaseFont: GHVNXU+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 31
      LastChar: 183
      FontDescriptor: 
       FontName: GHVNXU+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
     Font: 
      BaseFont: NQNDRG+Shaker2Lancet-Bold
      FontSubset: true
      FirstChar: 32
      LastChar: 121
      FontDescriptor: 
       FontName: NQNDRG+Shaker2Lancet-Bold
       Flags: Nonsymbolic
       FontBBox: -164, -241, 1109, 981
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GHVNXU+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 31
      LastChar: 121
      FontDescriptor: 
       FontName: GHVNXU+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
     Font: 
      BaseFont: NQNDRG+Shaker2Lancet-Bold
      FontSubset: true
      FirstChar: 66
      LastChar: 67
      FontDescriptor: 
       FontName: NQNDRG+Shaker2Lancet-Bold
       Flags: Nonsymbolic
       FontBBox: -164, -241, 1109, 981
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GHVNXU+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 65
      LastChar: 88
      FontDescriptor: 
       FontName: GHVNXU+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: NQNDRG+Shaker2Lancet-Bold
      FontSubset: true
      FirstChar: 65
      LastChar: 65
      FontDescriptor: 
       FontName: NQNDRG+Shaker2Lancet-Bold
       Flags: Nonsymbolic
       FontBBox: -164, -241, 1109, 981
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GHVNXU+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 32
      LastChar: 119
      FontDescriptor: 
       FontName: GHVNXU+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: NQNDRG+Shaker2Lancet-Bold
      FontSubset: true
      FirstChar: 32
      LastChar: 150
      FontDescriptor: 
       FontName: NQNDRG+Shaker2Lancet-Bold
       Flags: Nonsymbolic
       FontBBox: -164, -241, 1109, 981
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GHVNXU+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 31
      LastChar: 183
      FontDescriptor: 
       FontName: GHVNXU+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
     Font: 
      BaseFont: NQNDRG+Shaker2Lancet-Bold
      FontSubset: true
      FirstChar: 32
      LastChar: 121
      FontDescriptor: 
       FontName: NQNDRG+Shaker2Lancet-Bold
       Flags: Nonsymbolic
       FontBBox: -164, -241, 1109, 981
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GHVNXU+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 32
      LastChar: 134
      FontDescriptor: 
       FontName: GHVNXU+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GHVNXU+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 32
      LastChar: 215
      FontDescriptor: 
       FontName: GHVNXU+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: NQNDRG+Shaker2Lancet-Bold
      FontSubset: true
      FirstChar: 30
      LastChar: 242
      FontDescriptor: 
       FontName: NQNDRG+Shaker2Lancet-Bold
       Flags: Nonsymbolic
       FontBBox: -164, -241, 1109, 981
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: GHVNXU+Shaker2Lancet-Regular
      FontSubset: true
      FirstChar: 26
      LastChar: 183
      FontDescriptor: 
       FontName: GHVNXU+Shaker2Lancet-Regular
       Flags: Nonsymbolic
       FontBBox: -158, -241, 1019, 980
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: FZLHJW+Shaker2Lancet-Italic
      FontSubset: true
      FirstChar: 32
      LastChar: 122
      FontDescriptor: 
       FontName: FZLHJW+Shaker2Lancet-Italic
       Flags: Nonsymbolic, Italic
       FontBBox: -177, -241, 960, 980
       FontFile3: true
      Encoding: WinAnsiEncoding
      ToUnicode: true
     Font: 
      BaseFont: FZLHJW+ScalaLancetPro-Bold
      FontSubset: true
      FirstChar: 29
      LastChar: 183
      FontDescriptor: 
       FontName: FZLHJW+ScalaLancetPro-Bold
       Flags: Serif, Nonsymbolic
       FontBBox: -62, -271, 1199, 922
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: FZLHJW+ScalaLancetPro-Italic
      FontSubset: true
      FirstChar: 32
      LastChar: 118
      FontDescriptor: 
       FontName: FZLHJW+ScalaLancetPro-Italic
       Flags: Serif, Nonsymbolic
       FontBBox: -174, -271, 1200, 922
       FontFile3: true
      Encoding: WinAnsiEncoding
      ToUnicode: true
     Font: 
      BaseFont: FZLHJW+ScalaLancetPro
      FontSubset: true
      FirstChar: 27
      LastChar: 215
      FontDescriptor: 
       FontName: FZLHJW+ScalaLancetPro
       Flags: Serif, Nonsymbolic
       FontBBox: -64, -271, 1200, 922
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: FZLHJW+Shaker2Lancet-BoldItalic
      FontSubset: true
      FirstChar: 25
      LastChar: 118
      FontDescriptor: 
       FontName: FZLHJW+Shaker2Lancet-BoldItalic
       Flags: Nonsymbolic, Italic
       FontBBox: -185, -241, 1072, 981
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
   XMP: <x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 4.0-c316 44.253921, Sun Oct 01 2006 17:14:39">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:dc="http://purl.org/dc/elements/1.1/">
         <dc:format>application/pdf</dc:format>
         <dc:identifier>doi:10.1016/S1470-2045(18)30093-7</dc:identifier>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial</rdf:li>
            </rdf:Alt>
         </dc:title>
         <dc:creator>
            <rdf:Seq>
               <rdf:li>Timothy J Iveson MD</rdf:li>
               <rdf:li>Prof Rachel S Kerr FRCP</rdf:li>
               <rdf:li>Mark P Saunders FRCR</rdf:li>
               <rdf:li>Prof Jim Cassidy MD</rdf:li>
               <rdf:li>Niels Henrik Hollander MD</rdf:li>
               <rdf:li>Josep Tabernero MD</rdf:li>
               <rdf:li>Andrew Haydon MBBS</rdf:li>
               <rdf:li>Prof Bengt Glimelius MD</rdf:li>
               <rdf:li>Andrea Harkin BA</rdf:li>
               <rdf:li>Karen Allan BSc</rdf:li>
               <rdf:li>John McQueen BSc</rdf:li>
               <rdf:li>Claire Scudder MSc</rdf:li>
               <rdf:li>Kathleen Anne Boyd PhD</rdf:li>
               <rdf:li>Prof Andrew Briggs DPhil</rdf:li>
               <rdf:li>Ashita Waterston PhD</rdf:li>
               <rdf:li>Louise Medley FRCP</rdf:li>
               <rdf:li>Charles Wilson FRCR</rdf:li>
               <rdf:li>Richard Ellis FRCR</rdf:li>
               <rdf:li>Sharadah Essapen MD</rdf:li>
               <rdf:li>Amandeep S Dhadda MBChB</rdf:li>
               <rdf:li>Mark Harrison PhD</rdf:li>
               <rdf:li>Stephen Falk MD</rdf:li>
               <rdf:li>Sherif Raouf FRCR</rdf:li>
               <rdf:li>Charlotte Rees FRCP</rdf:li>
               <rdf:li>Rene K Olesen MD</rdf:li>
               <rdf:li>David Propper MD</rdf:li>
               <rdf:li>Prof John Bridgewater MD</rdf:li>
               <rdf:li>Ashraf Azzabi MD</rdf:li>
               <rdf:li>David Farrugia PhD</rdf:li>
               <rdf:li>Andrew Webb FRCP</rdf:li>
               <rdf:li>Prof David Cunningham MD</rdf:li>
               <rdf:li>Tamas Hickish MD</rdf:li>
               <rdf:li>Andrew Weaver MD</rdf:li>
               <rdf:li>Simon Gollins DPhil</rdf:li>
               <rdf:li>Harpreet S Wasan FRCP</rdf:li>
               <rdf:li>James Paul BSc [Hons]</rdf:li>
            </rdf:Seq>
         </dc:creator>
         <dc:subject>
            <rdf:Bag/>
         </dc:subject>
         <dc:description>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Lancet Oncology, 19 (2018) 562-578. doi:10.1016/S1470-2045(18)30093-7</rdf:li>
            </rdf:Alt>
         </dc:description>
         <dc:publisher>
            <rdf:Bag>
               <rdf:li>The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license</rdf:li>
            </rdf:Bag>
         </dc:publisher>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:prism="http://prismstandard.org/namespaces/basic/3.0/">
         <prism:aggregationType>journal</prism:aggregationType>
         <prism:publicationName>Lancet Oncology</prism:publicationName>
         <prism:copyright>Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. All rights reserved.</prism:copyright>
         <prism:issn>1470-2045</prism:issn>
         <prism:volume>19</prism:volume>
         <prism:number>4</prism:number>
         <prism:pageRange>562-578</prism:pageRange>
         <prism:startingPage>562</prism:startingPage>
         <prism:endingPage>578</prism:endingPage>
         <prism:doi>10.1016/S1470-2045(18)30093-7</prism:doi>
         <prism:url>http://dx.doi.org/10.1016/S1470-2045(18)30093-7</prism:url>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:crossmark="http://crossref.org/crossmark/1.0/">
         <crossmark:MajorVersionDate>2010-04-23</crossmark:MajorVersionDate>
         <crossmark:CrossmarkDomainExclusive>true</crossmark:CrossmarkDomainExclusive>
         <crossmark:DOI>10.1016/S1470-2045(18)30093-7</crossmark:DOI>
         <crossmark:CrossMarkDomains>
            <rdf:Seq>
               <rdf:li>elsevier.com</rdf:li>
               <rdf:li>sciencedirect.com</rdf:li>
            </rdf:Seq>
         </crossmark:CrossMarkDomains>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:jav="http://www.niso.org/schemas/jav/1.0/">
         <jav:journal_article_version>VoR</jav:journal_article_version>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:pdfx="http://ns.adobe.com/pdfx/1.3/">
         <pdfx:ElsevierWebPDFSpecifications>6.5</pdfx:ElsevierWebPDFSpecifications>
         <pdfx:doi>10.1016/S1470-2045(18)30093-7</pdfx:doi>
         <pdfx:robots>noindex</pdfx:robots>
         <pdfx:CrossmarkMajorVersionDate>2010-04-23</pdfx:CrossmarkMajorVersionDate>
         <pdfx:CrossmarkDomainExclusive>true</pdfx:CrossmarkDomainExclusive>
         <pdfx:CrossMarkDomains>
            <rdf:Seq>
               <rdf:li>sciencedirect.com</rdf:li>
               <rdf:li>elsevier.com</rdf:li>
            </rdf:Seq>
         </pdfx:CrossMarkDomains>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xap="http://ns.adobe.com/xap/1.0/">
         <xap:CreatorTool>Elsevier</xap:CreatorTool>
         <xap:CreateDate>2018-03-17T17:52:20+05:30</xap:CreateDate>
         <xap:ModifyDate>2018-04-13T11:04:56+05:30</xap:ModifyDate>
         <xap:MetadataDate>2018-04-13T11:04:56+05:30</xap:MetadataDate>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xapRights="http://ns.adobe.com/xap/1.0/rights/">
         <xapRights:Marked>True</xapRights:Marked>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/">
         <pdf:Keywords/>
         <pdf:Producer>Acrobat Distiller 6.0 for Windows</pdf:Producer>
         <pdf:Trapped>False</pdf:Trapped>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xapMM="http://ns.adobe.com/xap/1.0/mm/">
         <xapMM:DocumentID>uuid:d0f9a61e-a0fb-4a54-8924-89cca1a3c172</xapMM:DocumentID>
         <xapMM:InstanceID>uuid:a207186f-a3b9-4c94-bb2b-f6eb0af7e26a</xapMM:InstanceID>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
   Pages: 
    Page: 
     Label: 562
     Sequence: 1
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 86, 654, 110, 680
    Page: 
     Label: 563
     Sequence: 2
    Page: 
     Label: 564
     Sequence: 3
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 281, 496, 330, 485
    Page: 
     Label: 565
     Sequence: 4
    Page: 
     Label: 566
     Sequence: 5
    Page: 
     Label: 567
     Sequence: 6
    Page: 
     Label: 568
     Sequence: 7
    Page: 
     Label: 569
     Sequence: 8
    Page: 
     Label: 570
     Sequence: 9
    Page: 
     Label: 571
     Sequence: 10
    Page: 
     Label: 572
     Sequence: 11
    Page: 
     Label: 573
     Sequence: 12
    Page: 
     Label: 574
     Sequence: 13
    Page: 
     Label: 575
     Sequence: 14
    Page: 
     Label: 576
     Sequence: 15
    Page: 
     Label: 577
     Sequence: 16
    Page: 
     Label: 578
     Sequence: 17
  Checksum: c7e530da
   Type: CRC32
  Checksum: 058b0cd044411307dc4e4ad9c2339614
   Type: MD5
  Checksum: 0959e0b01a89cda1270fcab0b433b3961d380634
   Type: SHA-1